These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7949501)

  • 1. Mathematical examination of dual individualization principles (II): The rate of bacterial eradication at the same area under the inhibitory curve is more rapid for ciprofloxacin than for cefmenoxime.
    Goss TF; Forrest A; Nix DE; Ballow CH; Birmingham MC; Cumbo TJ; Schentag JJ
    Ann Pharmacother; 1994; 28(7-8):863-8. PubMed ID: 7949501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial action and pharmacokinetics/pharmacodynamics: the use of AUIC to improve efficacy and avoid resistance.
    Schentag JJ
    J Chemother; 1999 Dec; 11(6):426-39. PubMed ID: 10678784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistance.
    Schentag JJ; Birmingham MC; Paladino JA; Carr JR; Hyatt JM; Forrest A; Zimmer GS; Adelman MH; Cumbo TJ
    Semin Respir Infect; 1997 Dec; 12(4):278-93. PubMed ID: 9436955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mathematical examination of dual individualization principles (I): Relationships between AUC above MIC and area under the inhibitory curve for cefmenoxime, ciprofloxacin, and tobramycin.
    Schentag JJ; Nix DE; Adelman MH
    DICP; 1991 Oct; 25(10):1050-7. PubMed ID: 1803788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients.
    Forrest A; Nix DE; Ballow CH; Goss TF; Birmingham MC; Schentag JJ
    Antimicrob Agents Chemother; 1993 May; 37(5):1073-81. PubMed ID: 8517694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role for dual individualization with cefmenoxime.
    Schentag JJ; Smith IL; Swanson DJ; DeAngelis C; Fracasso JE; Vari A; Vance JW
    Am J Med; 1984 Dec; 77(6A):43-50. PubMed ID: 6097124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of pharmacokinetic parameters to efficacy of antibiotics: relationships between serum concentrations, MIC values, and bacterial eradication in patients with gram-negative pneumonia.
    Schentag JJ
    Scand J Infect Dis Suppl; 1990; 74():218-34. PubMed ID: 2097710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the ratio of the estimated area under the concentration-time curve to minimum inhibitory concentration (estimated AUIC) as a predictor of the outcome for tigecycline treatment for pneumonia due to multidrug-resistant bacteria in an intensive care unit.
    Xu Y; Jin L; Liu N; Luo X; Dong D; Tang J; Wang Y; You Y; Liu Y; Chen M; Yu Z; Hao Y; Gu Q
    Int J Infect Dis; 2019 May; 82():79-85. PubMed ID: 30878630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AUIC--a general target for the optimization of dosing regimens of antibiotics?
    Dalla Costa T; Derendorf H
    Ann Pharmacother; 1996 Sep; 30(9):1024-8. PubMed ID: 8876867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling the response of pneumonia to antimicrobial therapy.
    Hyatt JM; Luzier AB; Forrest A; Ballow CH; Schentag JJ
    Antimicrob Agents Chemother; 1997 Jun; 41(6):1269-74. PubMed ID: 9174182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mathematical examination of dual individualization principles. (III): Development of a scoring system for pneumonia staging and quantitation of response to antibiotics: results in cefmenoxime-treated patients.
    Luzier A; Goss TF; Cumbo TJ; Schentag JJ
    Ann Pharmacother; 1992 Nov; 26(11):1358-65. PubMed ID: 1477437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacodynamic interactions of antibiotics alone and in combination.
    Schentag JJ; Strenkoski-Nix LC; Nix DE; Forrest A
    Clin Infect Dis; 1998 Jul; 27(1):40-6. PubMed ID: 9675447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual individualization of intravenous ciprofloxacin in patients with nosocomial lower respiratory tract infections.
    Nix DE; Sands MF; Peloquin CA; Vari AJ; Cumbo TJ; Vance JW; Fracasso JE; Schentag JJ
    Am J Med; 1987 Apr; 82(4A):352-6. PubMed ID: 3555060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic dosing issues in lower respiratory tract infection: population-derived area under inhibitory curve is predictive of efficacy.
    Highet VS; Forrest A; Ballow CH; Schentag JJ
    J Antimicrob Chemother; 1999 Mar; 43 Suppl A():55-63. PubMed ID: 10225573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacoeconomic analysis of cefmenoxime dual individualization in the treatment of nosocomial pneumonia.
    Paladino JA; Fell RE
    Ann Pharmacother; 1994 Mar; 28(3):384-9. PubMed ID: 8193431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections.
    McKinnon PS; Paladino JA; Schentag JJ
    Int J Antimicrob Agents; 2008 Apr; 31(4):345-51. PubMed ID: 18313273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluoroquinolone AUIC break points and the link to bacterial killing rates. Part 1: In vitro and animal models.
    Schentag JJ; Meagher AK; Forrest A
    Ann Pharmacother; 2003 Sep; 37(9):1287-98. PubMed ID: 12921513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A disease model descriptive of progression between chronic obstructive pulmonary disease exacerbations and community-acquired pneumonia: roles for underlying lung disease and the pharmacokinetics/pharmacodynamics of the antibiotic.
    File TM; Monte SV; Schentag JJ; Paladino JA; Klugman KP; Lavin B; Yu VL; Singer ME; Adelman MH
    Int J Antimicrob Agents; 2009 Jan; 33(1):58-64. PubMed ID: 18835762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of minimal inhibitory concentration and bactericidal activity to efficacy of antibiotics for treatment of ventilator-associated pneumonia.
    Kiem S; Schentag JJ
    Semin Respir Crit Care Med; 2006 Feb; 27(1):51-67. PubMed ID: 16508882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial resistance in nosocomial bloodstream infection associated with pneumonia and the value of systematic surveillance cultures in an adult intensive care unit.
    Depuydt PO; Blot SI; Benoit DD; Claeys GW; Verschraegen GL; Vandewoude KH; Vogelaers DP; Decruyenaere JM; Colardyn FA
    Crit Care Med; 2006 Mar; 34(3):653-9. PubMed ID: 16505649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.